Authors:
Avinash Singh, Amit Patil
Download free PDF
Insect Repellent Apparel Market Size & Share 2026-2035
Report ID: GMI10116
|
Published Date: September 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Insect Repellent Apparel Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Insect Repellent Apparel Market Size
The global insect repellent apparel market was estimated at USD 490.3 million in 2025 and is projected to reach USD 861.6 million by 2035, expanding at a 5.8% CAGR during 2026–2035.
Insect Repellent Apparel Market Key Takeaways
Market Leader: Columbia Sportswear Company led with over 9% market share in 2025.
Leading Players: Top 5 players in this market include Columbia Sportswear Company, L.L.Bean, Inc., Craghoppers Ltd., ExOfficio LLC, Insect Shield LLC, which collectively held a market share of 24% in 2025.
These are modeled, demand-side analyst estimates; the 2025 estimate carries a USD 460 million–USD 530 million range because no government agency or trade body separately reports global insect repellent apparel revenue.
The category covers factory-treated garments, plant-based treated clothing, mechanically protective apparel, hybrid products, and wearable accessories intended to limit exposure to mosquitoes, ticks, flies, and other vectors. Its demand base is broader than outdoor leisure: institutional procurement by forestry, agricultural, utility, military, and grounds-maintenance employers creates a separate purchasing pathway in which treatment durability, labeling, and worker acceptance matter as much as style.
Disease exposure is making the purchase decision more preventive and less discretionary in several markets. WHO recorded 14.4 million dengue cases globally in 2024, the highest annual total reported to that point [1]World Health Organization, WHO Weekly Epidemiological Record, Vol. 99, No. 52: Dengue 2024 update. who.int. WHO also estimates that approximately four billion people across more than 130 countries are at risk from dengue and other Aedes-borne diseases. Malaria remains a major exposure concern in tropical travel and occupational settings, with an estimated 282 million cases and 610,000 deaths in 2024. In the United States, 89,468 Lyme disease cases were officially reported in 2023, while CDC estimates indicate that roughly 476,000 people are diagnosed and treated for Lyme disease each year.
Regulation provides a defined commercial foundation for treated apparel, particularly in the United States. Permethrin is the only active ingredient registered by the U.S. Environmental Protection Agency for factory-applied insect repellency on clothing; EPA notes military approval in 1990 and consumer approval in 2003 [2]U.S. Environmental Protection Agency, Repellent-Treated Clothing. epa.gov. CDC recommends clothing, boots, and gear treated with 0.5% permethrin as part of tick-bite prevention. This framework favors manufacturers that can substantiate treatment claims, wash instructions, and product labeling, while creating a higher compliance threshold for new treatment technologies.
GMI Analyst View
The market's growth is governed by an interaction between exposure risk and product credibility. Rising disease awareness can generate category trial, but repeat purchases depend on whether apparel remains wearable, clearly labeled, and credible after laundering. The category therefore differs from conventional outdoor clothing: its commercial value is tied to prevention utility, regulatory treatment status, and the consumer's confidence in the protection claim.
The forecast from USD 490 million in 2025 to USD 861 million in 2035 reflects a shift from a specialist outdoor category toward a more segmented protective-apparel market. North America continues to supply the deepest base of outdoor retail and institutional demand, while Asia Pacific contributes the fastest modeled growth as vector exposure, e-commerce reach, and functional-apparel adoption converge. The central strategic tension is that the established synthetic platform has the strongest regulatory familiarity, whereas the fastest expansion is expected from plant-based and hybrid alternatives.
Key Drivers
Vector-borne disease prevention is the category's strongest demand catalyst because apparel can provide continuous coverage without repeated topical application. CDC states that vector-borne disease incidence in the United States has doubled over the past two decades and has set a target to reduce confirmed Lyme disease cases by 25% by 2035 [3]Centers for Disease Control and Prevention, National Strategy for the Prevention and Control of Vector-Borne Diseases in People. cdc.gov. This raises the commercial relevance of protective clothing in tick-endemic recreation areas, suburban settings, and occupations that involve repeated vegetation exposure.
Outdoor recreation increases the addressable audience, but it also changes product requirements. Recreational consumers expect insect protection to coexist with breathability, sun protection, moisture management, and styling appropriate for hiking, fishing, travel, hunting, and golf. The 175.8 million U.S. outdoor-recreation participants reported for 2023 demonstrate the scale of the potential consumer base, although this figure should not be represented as 2024 participation [4]Outdoor Foundation, 2024 Outdoor Participation Trends Report: Executive Summary. outdoorrecreation.wi.gov. Brands that integrate protection into garments used for ordinary outdoor activity have a lower barrier to adoption than products positioned solely as emergency or travel protection.
Occupational demand provides a more stable counterweight to seasonal consumer purchases. In a study of outdoor workers using long-lasting permethrin-impregnated clothing, 83% reported wearing the garments all or most of the time at work. For employers, the value proposition is not merely a treated garment; it is a deployable item that can fit uniform specifications, laundering routines, and worker-acceptance requirements. This favors suppliers with traceable treatment processes and practical replacement guidance.
Regulatory recognition reinforces the synthetic segment's installed base. EPA's factory-treatment registration framework and CDC's recommendation for 0.5% permethrin-treated clothing make permethrin the most familiar active ingredient for U.S. consumers and procurement managers. In Europe, the Biocidal Products Regulation requires active-substance evaluation and authorization discipline; the European Commission extended permethrin approval through October 2028. This regulatory continuity supports existing product lines, but the review process also increases the value of substantiated efficacy and compliance documentation.
Key Restraints
Treatment longevity is a material constraint because the product promise is evaluated over repeated use and laundering. The occupational study showing no detectable permethrin in 33% of tested garments after one year does not establish a uniform decline rate, but it demonstrates substantial real-world variability. A brand that overstates wash durability can weaken consumer trust, while a brand that communicates realistic care and replacement expectations may protect long-term category credibility.
Premium pricing limits penetration where conventional clothing remains the default substitute. Consumers in price-sensitive markets may recognize insect exposure yet continue to use low-cost topical repellents, nets, or untreated long-sleeve clothing rather than purchase specialized apparel. The constraint is strongest when the treated garment does not provide additional comfort, weather protection, or use beyond insect season. This makes product versatility central to value realization.
Natural alternatives face a different restraint: the need to demonstrate performance and regulatory status without implying equivalence that is not supported. Eucalyptus Citriodora Oil-based substances remain under assessment for PT19 use under the EU biocides framework, rather than being universally approved for insect-repellent clothing. Suppliers must therefore avoid treating "plant-based" as a substitute for documented efficacy, durability, or jurisdiction-specific authorization.
GMI Analyst View
The restraint profile points to a market where growth cannot be sustained through health messaging alone. Disease risk creates interest, but the repeat-purchase equation is determined by treatment retention, garment comfort, and the perceived price of dependable protection. This is especially consequential for synthetic products: regulatory familiarity helps initial conversion, yet variable real-world retention can turn durability communication into a decisive competitive variable.
Natural and hybrid products may widen the addressable audience, but they do not eliminate the evidence burden. Their strongest opportunity lies where suppliers can pair a plant-derived or dual-action proposition with clear jurisdictional compliance and realistic performance claims. In practice, the next share gains will accrue to companies that make protection understandable at the point of sale, rather than those that rely on a generic "insect-repellent" label.
Insect Repellent Apparel Market Segment Analysis
By Product Type
Shirts are the largest product category, estimated at USD 157 million in 2025 and projected to reach USD 258 million by 2035, growing at a 5.1% CAGR. Their lead reflects broad applicability across outdoor recreation, travel, and workwear, where long-sleeve upper-body coverage can be incorporated into everyday apparel rather than purchased as specialized protective equipment.
Trousers/pants are estimated to rise from USD 122 million in 2025 to USD 207 million in 2035 at a 5.4% CAGR. Demand benefits from full-body protection needs in brush, grassland, and wetland environments, particularly where occupational or hunting use makes lower-body coverage non-negotiable.
Jackets are the fastest-growing product type, forecast to expand from USD 98 million in 2025 to USD 189 million in 2035 at a 6.8% CAGR. Their higher growth reflects the ability to combine insect protection with weather resistance and layering utility, raising the acceptable price point for dawn, evening, shoulder-season, and travel use.
Head covers/nets are projected to increase from USD 49 million in 2025 to USD 86 million in 2035. The others category, including socks, gear, and accessories, is expected to grow from USD 64 million to USD 121 million at a 6.6% CAGR. These products often function as add-on purchases that raise basket value and allow consumers to address localized exposure without replacing an entire wardrobe.
By Treatment Technology
Synthetic chemical-based apparel, principally permethrin-treated products, remains the largest technology segment, estimated at USD 353 million in 2025 and projected to reach USD 534 million by 2035. Its 4.2% CAGR is below the market average, but its scale reflects established factory-treatment infrastructure, EPA recognition in the United States, and a long history of use in outdoor and occupational applications.
Natural/plant-based apparel is forecast to grow from USD 98 million in 2025 to USD 241 million in 2035, representing the fastest technology CAGR at 9.4%. The segment's opportunity is driven by consumers seeking alternatives to conventional synthetic chemistry, particularly in European travel and outdoor markets. Its commercial expansion will be governed by whether brands can substantiate product performance and navigate varying biocidal requirements rather than by plant-derived positioning alone.
Hybrid/dual-action apparel is modeled to rise from USD 39 million to USD 86 million at an 8.2% CAGR. This segment includes designs that combine mechanical barriers with treatment technology or otherwise pair multiple protection mechanisms. Its value proposition is strongest in premium uses where consumers prioritize coverage and garment functionality over low entry price.
By Price
Low-price offerings can extend trial among occasional users, but their commercial viability depends on avoiding a perceived compromise in comfort, treatment credibility, or garment life. Medium-price products represent the practical bridge between mainstream outdoor apparel and premium protective clothing, particularly when offered through specialty retail and e-commerce. High-price products are supported by technical fabrics, multi-season functionality, branded treatment platforms, and use cases such as hunting, expedition travel, professional fieldwork, and institutional uniforms. No market values are assigned to these price tiers because approved modeled estimates were not provided.
By End User
Men remain a core audience in fishing, hunting, trades, and field-work categories, while women's demand is increasingly tied to hiking, travel, gardening, and outdoor lifestyle applications. Kids' apparel emphasizes parental risk management, fit, and simplified care instructions. Pet products are included only where wearable insect-repellent apparel is sold; this subsegment follows different fit, replacement, and retail dynamics from human apparel. Product developers must therefore avoid assuming that one technical silhouette or treatment message translates across all end-user groups.
By Application
Outdoor and recreation is the broadest application, supported by camping, fishing, hiking, hunting, and nature travel. Military and defense demand favors certified, repeatable treatment systems and uniform compatibility. Travel and tourism use is linked to destination-specific mosquito awareness and the preference for low-maintenance protection during multi-day trips. Healthcare and industrial applications depend more directly on employer protocols, exposure assessments, uniform standards, and laundering practices. Other applications include gardening, wildlife observation, and localized household outdoor use. These application segments are qualitative because no approved market values were supplied.
By Distribution Channel
Offline channels lead the market in 2025 with an estimated USD 289 million, compared with USD 201 million online. Specialty outdoor and sports stores remain valuable because staff can explain treatment claims, fit, wash care, and use conditions. Supermarkets, hypermarkets, workwear distributors, and other physical outlets widen access where insect protection is bought alongside seasonal or travel needs.
Online sales are forecast to grow from USD 201 million in 2025 to USD 447 million in 2035 at an 8.3% CAGR, overtaking offline revenue by the end of the forecast horizon. Digital channels improve access to niche sizing, detailed care instructions, product comparison, and brand-direct assortments. Columbia Sportswear's FY2024 direct-to-consumer revenue of USD 1.634 billion, alongside USD 2.687 billion in apparel, accessories, and equipment revenue, illustrates the scale of digital and direct retail infrastructure available to large outdoor-apparel suppliers, although these figures are not insect-repellent-apparel revenue [5]Columbia Sportswear Company, Form 10-K for the Fiscal Year Ended. sec.gov. AI and generative-AI tools may improve product discovery, recommendation, and demand planning, but no approved evidence supports assigning a quantified market effect to them.
GMI Analyst View
Segment growth is shifting value toward products that solve more than one problem. Jackets gain because they combine weather protection and insect defense; accessories gain because they lower the cost of completing a protection system; and hybrid designs gain where users want reassurance beyond a single treatment mechanism. This favors modular assortments rather than a narrow range of treated shirts.
The technology mix reveals a more consequential transition. Permethrin will remain the revenue anchor because it has the clearest established regulatory pathway in the United States, yet natural/plant-based apparel is projected to grow more than twice as fast. The competitive task is therefore not to replace synthetic products wholesale, but to maintain evidence-backed synthetic lines while building natural alternatives that meet credible performance and regulatory thresholds.
The channel shift compounds this change. Offline retail remains important for education and fit, whereas online growth rewards brands that translate technical claims into clear, comparable product information. Suppliers that can coordinate treatment disclosures, wash-care guidance, and inventory across both channels will be better positioned than brands treating e-commerce as a secondary clearance route.
Insect Repellent Apparel Market Regional Analysis
North America
North America is the largest modeled regional market, estimated at USD 220 million in 2025 and projected to reach USD 327 million by 2035 at a 4.1% CAGR. The United States accounts for USD 200 million of 2025 regional revenue and is forecast to reach USD 293 million by 2035; Canada contributes USD 20 million in 2025 and is projected to reach USD 34 million. The region combines a developed performance-apparel retail base with high awareness of tick prevention, a large outdoor-workforce base, and established regulatory recognition for factory-treated permethrin apparel.
Europe
Europe is estimated at USD 108 million in 2025 and is projected to reach USD 189 million by 2035, growing at 5.8% CAGR. The UK is the largest identified country market at USD 35 million in 2025, followed by Germany at USD 21 million, France at USD 17 million, Italy at USD 14 million, and Spain at USD 12 million. Europe's demand profile is shaped by outdoor travel, country pursuits, mosquito and tick exposure, and a regulatory environment that gives treatment chemistry greater visibility in product development decisions. WHO has identified the geographic expansion of dengue risk into southern Europe, adding a public-health dimension to a market previously centered more heavily on travel and countryside recreation.
Asia Pacific
Asia Pacific is projected to be the fastest-growing region, rising from USD 98 million in 2025 to USD 224 million by 2035 at an 8.6% CAGR. China leads regional revenue at USD 27 million in 2025 and is forecast to reach USD 66 million; India is expected to rise from USD 15 million to USD 44 million; Japan from USD 21 million to USD 38 million; Australia from USD 17 million to USD 30 million; and South Korea from USD 10 million to USD 23 million. The region's acceleration reflects the combination of disease awareness, expanding digital retail access, travel, and growing demand for functional apparel. Pricing remains a decisive issue: high growth does not automatically translate into premium conversion in markets where untreated clothing and topical repellents remain lower-cost substitutes.
Latin America
Latin America is estimated at USD 34 million in 2025 and is forecast to reach USD 69 million by 2035, at a 7.3% CAGR. Brazil leads the region at USD 18 million in 2025, followed by Mexico at USD 10 million and Argentina at USD 4 million. Mosquito-borne disease awareness supplies a strong rationale for prevention products, but market development depends on whether brands can offer suitable price points and distribution beyond travel-oriented or premium urban retail.
Middle East & Africa
The Middle East and Africa market is projected to rise from USD 30 million in 2025 to USD 52 million by 2035, a 5.7% CAGR. The UAE and Saudi Arabia each represent USD 8 million in 2025, while South Africa represents USD 6 million. Demand is linked to travel, outdoor work, safari and recreation activity, and the need for climate-appropriate lightweight garments. Product suitability for heat, laundering access, and local retail economics is likely to matter more than standardized global assortments.
GMI Analyst View
Regional expansion is not a simple function of disease burden. North America remains the largest market because disease awareness is reinforced by high outdoor-apparel spending, established specialty distribution, and recognized treated-clothing guidance. Asia Pacific grows faster because it begins from a smaller revenue base while gaining access through online channels and functional-apparel adoption. The difference means that North America rewards assortment depth and institutional credibility, whereas Asia Pacific rewards price architecture, digital discovery, and climate-appropriate design.
Europe occupies an important middle position. Its 5.8% projected CAGR reflects developed outdoor demand and a policy environment that makes treatment chemistry commercially visible. Suppliers entering the region need to treat regulatory diligence as part of the product proposition, especially when advancing natural alternatives. Latin America and the Middle East and Africa offer meaningful growth potential, but their demand cannot be captured through a uniform premium strategy; local price sensitivity and product-use conditions will determine whether awareness converts into recurring apparel purchases.
Insect Repellent Apparel Market Share & Competitive Landscape
The market is highly fragmented. Columbia Sportswear is the largest modeled participant, with an estimated 8.4% share and approximately USD 41 million of insect-repellent-apparel revenue in 2025. L.L.Bean is estimated at 5.3% or approximately USD 26 million, Craghoppers at 4.3% or approximately USD 21 million, ExOfficio and Outdoor Research combined at 3.3% or approximately USD 16 million, and Insect Shield at 2.4% or approximately USD 12 million. The top five brands collectively hold approximately 25% of the market, leaving substantial share with listed specialists and unlisted regional suppliers. These are analyst-modeled estimates, not company-disclosed insect-repellent-apparel revenue.
Columbia competes through broad outdoor-apparel distribution and direct consumer reach. Its FY2024 filing reported USD 2.687 billion in apparel, accessories, and equipment revenue and USD 1.634 billion in direct-to-consumer revenue. L.L.Bean's estimated insect-repellent-apparel position is supported by its outdoor and travel brand relevance; its reported 2025 revenue was approximately USD 1.7 billion, broadly flat for a third year [6]SGB Media, L.L.Bean Sees Flat Sales for Third Straight Year, Employee Bonus Shrinks to 6 Percent. sgbonline.com. These company-wide figures demonstrate retail scale, not a disclosed treatment-apparel sales split.
Craghoppers has a more concentrated insect-protection identity through its NosiLife range. The company recorded approximately GBP 43.9 million in turnover for the year ending January 31, 2025 [7]Pomanda, Craghoppers Limited: Company Financial Information. pomanda.com. Insect Shield occupies a distinct position as a treatment-platform provider, which can extend category reach across partner brands rather than relying solely on a single consumer apparel label.
The approved company scope also includes Tyndale USA, Simms Fishing Products, Rohan Designs Ltd., Borne Clothing, The Original Bug Shirt Co., Royal Robbins LLC, Gamehide / ElimiTick, Dog Not Gone, FORLOH Inc., Pang Wangle, Peskys, Rynoskin Total (Har-Son Inc.), Bug Baffler, SITKA Gear, and RailRiders. Competitive differentiation is likely to come from a combination of treatment credibility, garment fit and comfort, occupational-channel access, outdoor-community relevance, and the ability to explain durability limitations without diminishing consumer confidence.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →